SCOOP: XRHealth files $20.1M in securities, mostly for acquisitions
The October 23rd SEC filings disclose $2.15M in cash sales, shares issued to settle debt and $16.25M in acquisition consideration. PitchBook separately records a $22.8M September Series A1; the filings do not establish whether the transactions are related.
By Ryan Merket · Published
Primary source: SEC
Why it matters
The October filings disclose $20.13M in securities, but just $2.15M in cash sales. The rest is acquisition consideration and debt relief, and the documents do not show whether the transactions connect to PitchBook's reported September Series A1.
XRHealth founder and CEO Eran Orr signed two Form D notices accepted by the SEC on October 23rd, disclosing $20.13 million in securities offered and sold. Only $2.15 million is identified as cash.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.